Chargement en cours...
Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation
BACKGROUND: Cilostazol, an anti-platelet drug for treating coronary heart disease, has been reported to modulate immune cell functions. Plasmacytoid dendritic cells (pDCs) have been found to participate in the progression of atherosclerosis mainly through interferon α (IFN-α) production. Whether cil...
Enregistré dans:
| Publié dans: | J Geriatr Cardiol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Science Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4554787/ https://ncbi.nlm.nih.gov/pubmed/26345215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2015.04.011 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|